James Remmes v. HHS - Influenza, acute disseminated encephalomyelitis (2021)
Case summary [AI summaries can sometimes make mistakes]
On May 17, 2019, James Remmes filed a petition in the National Vaccine Injury Compensation Program alleging that he developed acute disseminated encephalomyelitis (ADEM) as a result of an influenza vaccine received on September 18, 2017. The respondent denied that Mr.
Remmes suffered from ADEM, that the vaccine caused his alleged injury, or that his current condition was a sequela of a vaccine-related injury. Despite these denials, the parties reached a stipulation recommending an award of compensation.
Special Master Nora Beth Dorsey reviewed the stipulation and found it reasonable, adopting it as the decision of the Court. The stipulation provided for a lump sum award of $176,625.00, payable to Mr.
Remmes, as compensation for all damages. The parties waived their right to seek review, and judgment was entered accordingly.
Ronald Craig Homer represented the petitioner, and Mitchell Jones represented the respondent.
Theory of causation
Petitioner James Remmes alleged that an influenza vaccine administered on September 18, 2017, caused him to develop acute disseminated encephalomyelitis (ADEM). Respondent denied the alleged injury, causation, and sequela. The parties reached a stipulation for compensation, which was adopted by Special Master Nora Beth Dorsey. The public decision does not describe the specific medical onset, symptoms, diagnostic tests, treatments, or expert witnesses. The award was a lump sum of $176,625.00 for all damages. Petitioner was represented by Ronald Craig Homer, and respondent was represented by Mitchell Jones. The decision date was November 8, 2021.
Source PDFs
USCOURTS-cofc-1_19-vv-00736